IRMD — IRADIMED CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1325618 ·
Last close
$85.76
Market Cap
$1.10B
52W High
$107.20
52W Low
$66.92
ADV30
115,390
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 20,466,000 | 15,160,000 | 6,391,000 | 5,218,000 | 114,975,000 | 59,080,000 | 13,227,000 |
| Mar 2026 | 21,979,000 | 16,814,000 | 7,237,000 | 5,818,000 | 114,389,000 | 56,374,000 | 15,875,000 |
| Dec 2025 | 22,691,899 | 17,031,894 | 7,093,797 | 6,441,958 | 108,776,000 | 51,159,000 | 14,158,000 |
| Sep 2025 | 21,202,064 | 16,494,308 | 6,833,750 | 5,576,652 | 114,721,779 | 56,526,151 | 16,369,808 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$28,945,000
Investing CF
$-4,973,000
Financing CF
$-17,929,000
CapEx
$-4,973,000
Dividends Paid
$-15,434,000
Buybacks
—
EPS Diluted TTM
$1.83
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$67,493,000
Inventory
$11,883,000
Receivables
$13,415,000
ST Investments
—
EBIT TTM
$27,952,544
Pretax Income TTM
$30,184,571
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$86,338,000
EBITDA
$29,184,000
Free Cash Flow
$16,196,160
Enterprise Value
$992,266,432
Total Cash
$59,080,000
Total Debt
$0
Shares Out
12,786,991
Trailing EPS
$1.79
Book Value
$7.96
ROE
23.5%
ROA
15.6%
Div Yield
0.97%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 83,814,000 | 26,147,000 | 22,480,000 | 108,776,000 | 14,158,000 | 94,618,000 | 24,947,000 |
| Dec 2024 | 73,242,000 | 21,965,000 | 19,234,000 | 98,326,000 | 11,507,000 | 86,819,000 | 25,624,000 |
| Dec 2023 | 65,562,296 | 20,035,458 | 17,192,776 | 92,156,098 | 20,735,934 | 71,420,164 | 13,465,012 |
| Dec 2022 | 53,303,145 | 15,627,645 | 12,828,487 | 85,513,747 | 11,840,760 | 73,672,987 | 10,042,711 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$2.41
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $85.00 · spot: $87.21 · call volume: 32 · put volume: 16
Expected Move to 2026-10-16:
±$6.55
(7.51%) —
implied range
$80.66 –
$93.76
· ATM straddle on $85.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TNDM | TANDEM DIABETES CARE INC | $1.09B | $15.72 | — |
| AORT | ARTIVION, INC. | $1.10B | $22.63 | — |
| ENOV | Enovis CORP | $1.06B | $18.46 | — |
| CDRE | Cadre Holdings, Inc. | $1.13B | $26.39 | — |
| STVN | Stevanato Group S.p.A. | $1.05B | $21.13 | — |
News headlines (Yahoo Finance, 1h cache)
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
2026-09-23 13:00 · Yahoo
IRadimed (IRMD) Q2 2026 Earnings Call Transcript
2026-08-08 02:44 · Yahoo
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors
2026-08-07 18:11 · Yahoo
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ...
2026-08-04 03:01 · Yahoo
iRadimed Q2 Earnings Call Highlights
2026-07-31 17:04 · Yahoo
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline
2026-07-27 13:48 · Yahoo
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
2026-06-02 12:29 · Yahoo
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report
2026-05-27 21:18 · Yahoo
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
2026-05-26 01:02 · Yahoo
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-20 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.